The global hematopoietic stem cell transplantation market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The Major driver in the hematopoietic stem cell transplantation market is the growing network of hematopoietic stem cell transplantation organizations that have reached across the globe and have been seen by an NGO called the Worldwide Network for Blood and Marrow Transplantation Group officially affiliated with the World Health Organization. The growing network has boosted the market owing to the joint ventures which have developed the technology to show the good result to the people which leads them to grow faith in the transplant for health issues. For instance, in July 2019, Omeros Corporation and Lonza announced a long-term manufacturing agreement for the commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), also referred to as OMS721. Omeros is preparing to submit a biologics license application (BLA) and a marketing authorization application (MAA) to the U.S. Food and Drug Administration (FDA) and to the European Medicines Agency (EMA), respectively, for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA).
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/hematopoietic-stem-cell-transplantation-market
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Transplant Type
- By Indication
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including Lonza Group, Merck & Co. Inc., Pluristem Therapeutics Inc., and others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected regions and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
A full report of Global Hematopoietic Stem Cell Transplantation Market available @ https://www.omrglobal.com/industry-reports/hematopoietic-stem-cell-transplantation-market
Global Hematopoietic Stem Cell Transplantation Market Report by Segment
By Transplant Type
- Allogenic
- Autologous
By Indication
- Acute Myeloid Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Hodgkin lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)
- Multiple Myeloma (MM)
- Others
By Application
- Bone Marrow Transplant (BMT)
- Peripheral Blood Stem Cells Transplant (PBSCT)
- Others
Global Hematopoietic Stem Cell Transplantation Market by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
